ArticleCureus2025
Reverse Shoulder Arthroplasty in Patients With Rheumatoid Arthritis and Polymyalgia Rheumatica: A Clinical and Functional Review at Two Years.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The moderating role of negative affect on pain in patients with rheumatoid arthritis who have undergone shoulder arthroplasty.Journal of orthopaedic surgery and research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) and polymyalgia rheumatica (PMR) are chronic inflammatory conditions that can lead to destruction and disability of the glenohumeral joint, requiring joint replacement. Disease processes can lead to further joint erosion and eventual loosening of the glenoid component of an anatomical total shoulder arthroplasty. The use of reverse shoulder arthroplasty (RSA) for RA is widely discussed; however, there is a lack of evidence relating to the use of this procedure for PMR. We conducted this study to compare outcomes of RSA in the treatment of RA and PMR. We conducted a retrospective analysis of 30 RSA procedures, of which 18 were for RA and 12 were for PMR. All patients had significant rotator cuff damage. All patients received the same implant and the same rehabilitation protocol and were followed up at the same four intervals. At each follow-up, we assessed the range of motion and Oxford shoulder score (OSS) and undertook a radiological assessment. We found a significant increase in the reported OSS and range of motion in both groups. We noted improvements in forward flexion, abduction and external rotation in both groups. We identified a significant increase in the OSS and post-operative range of motion after RSA in patients with RA when compared to PMR. In conclusion, RSA remains a viable option for patients with inflammatory arthritis. However, patients with PMR show less pronounced improvement compared to those with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.